Literature DB >> 9766719

Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.

S C Rankin1, H Taylor, G J Cook, R Mason.   

Abstract

UNLABELLED: Because patients with carcinoma of the oesophagus usually present with advanced disease and surgery has a high mortality with cure in less than 10% of patients, pre-operative staging to select appropriate patients is necessary. Computed tomography (CT) plays an important role in staging but has well recognized limitations. Positron emission tomography (PET) which provides physiological information may therefore be a better alternative.
OBJECTIVE: To compare the findings of CT and positron emission tomography (PET) with 2-[18fluorine]-fluoro-2-deoxy-D-glucose (FDG) in the pre-operative staging of oesophageal carcinoma.
MATERIALS AND METHODS: Twenty-five patients with biopsy proven oesophageal cancer had pre-operative staging using CT and FDG-PET. The studies were read independently and full histological confirmation was obtained in 19 patients. Four parameters were studied: the primary tumour, peri-oesophageal lymph nodes, liver metastases and left gastric lymph nodes.
RESULTS: PET visualized all primary tumours; CT missed one. CT identified 4/8 patients with involved peri-oesophageal nodes and PET 3/8. CT identified 5/9 patients with left gastric adenopathy and PET 1/9. PET visualized a liver metastasis missed on CT and appeared to be better in assessing residual tumour. PET did identify distant metastases not seen on CT in seven patients.
CONCLUSIONS: The two techniques are both effective in showing the primary tumour and about equally sensitive in the demonstration of peri-oesophageal nodes. PET is probably more sensitive than CT for the detection of distant metastases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766719     DOI: 10.1016/s0009-9260(98)80292-4

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  15 in total

Review 1.  Oesophageal surgery.

Authors:  E J Simchuk; D Alderson
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer.

Authors:  Cuong P Duong; Helen Demitriou; Leann Weih; Anne Thompson; David Williams; Robert J S Thomas; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-10       Impact factor: 9.236

3.  A suspected [18F]fluorodeoxyglucose positron emission tomography-negative metastatic lymph node successfully diagnosed by laparoscopic staging in esophageal cancer: report of two cases.

Authors:  Atsushi Takeno; Shuji Takiguchi; Makoto Yamasaki; Hiroshi Miyata; Ryohei Kawabata; Yoichiro Nushijima; Tomoki Makino; Yoshiyuki Fujiwara; Kiyokazu Nakajima; Toshiro Nishida; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

4.  Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma.

Authors:  S H Kim; K-N Lee; E J Kang; D W Kim; S H Hong
Journal:  Br J Radiol       Date:  2011-02-08       Impact factor: 3.039

5.  Overview of esophageal cancer.

Authors:  Ghulam Abbas; Mark Krasna
Journal:  Ann Cardiothorac Surg       Date:  2017-03

6.  2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.

Authors:  Hossein Jadvar; Robert W Henderson; Peter S Conti
Journal:  Mol Imaging Biol       Date:  2006 May-Jun       Impact factor: 3.488

7.  The early use of PET-CT alters the management of patients with esophageal cancer.

Authors:  R N Williams; S S Ubhi; C D Sutton; A L Thomas; J J Entwisle; D J Bowrey
Journal:  J Gastrointest Surg       Date:  2009-01-28       Impact factor: 3.452

8.  Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach?

Authors:  Werner Kneist; Mathias Schreckenberger; Peter Bartenstein; Frank Grünwald; Katja Oberholzer; Theodor Junginger
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

9.  [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].

Authors:  W Kneist; M Schreckenberger; P Bartenstein; F Grünwald; K Oberholzer; Th Junginger
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

10.  18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome.

Authors:  Marinke Westerterp; Gerrit W Sloof; Otto S Hoekstra; Fiebo J W Ten Kate; Gerrit A Meijer; Johannes B Reitsma; Ronald Boellaard; J Jan B van Lanschot; Carla F M Molthoff
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-25       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.